Compare Injective (INJ) vs Sui (SUI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Injective vs Sui — how do they compare? Injective trades at Rp75,948 (market cap Rp7,68T, Rp1,11T 24h volume), while Sui trades at Rp12,067 (market cap Rp49,26T, Rp2,41T 24h volume). The key difference: Sui is far larger — about 6.4× Injective's market cap, and Sui's supply is capped (4,1B / 10B SUI (41%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 37 Days and Sui for 37 Days on average.
| INJ | SUI | |
|---|---|---|
Market Cap | Rp7,68T | Rp49,26T |
Volume (24h) | Rp1,11T | Rp2,41T |
Circulating Supply | 100M INJ | 4,1B / 10B SUI (41%) |
Typical Hold Time | 37 Days | 37 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Injective (INJ) is currently trading at Rp75,554 with a market cap of Rp7.49T, exhibiting a bearish technical signal as indicated by moving averages. The asset trades below its pivot point of Rp82,186, with key support at Rp81,456 and resistance at Rp82,576. Recent on-chain data shows an average hold time of 37 days, suggesting moderate holding behavior.
The overall outlook is cautious due to bearish technical indicators and neutral oscillators. Key opportunities lie in potential rebounds from support levels, while major risks include high volatility and the absence of recent significant protocol updates. Investors should monitor trading volume and broader crypto market trends closely.
Sui is currently trading at Rp12,080 with a market cap of Rp49.09T, showing bearish technical signals as moving averages indicate selling pressure while oscillators remain neutral. The asset has 41% circulating supply with a relatively short 37-day average hold time. Current price sits between key support at Rp12,181 and resistance at Rp12,473, suggesting consolidation within a defined range.
Overall outlook remains cautious with bearish technical bias. Key opportunities include potential protocol growth and ecosystem expansion, while major risks involve high volatility and the asset's early adoption phase. Investors should monitor support levels closely and consider the limited circulating supply dynamics.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Injective
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →About Sui
Sui is a first-of-its-kind Layer-1 blockchain and smart contract platform designed from the bottom up to make digital asset ownership fast, private, secure, and accessible to everyone. Based on the Move programming language, its object-centric model enables parallel execution, sub-second finality, and rich on-chain assets. Sui supports a wide range of applications with unrivaled speed at a low cost.
Read more on SUI →
